SLC12A5 and central nervous system cancer: Two predicted‐enhancer peaks of SLC12A5 in chromatin 20 were more open in LGG than GBM and its expression were also obviously decreased in glioma tissue indicating its tumour suppressor role in glioma (Figure 1E).